Cirugía y Cirujanos

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board

>Journals >Cirugía y Cirujanos >Year 2002, Issue 2

Mendoza-Morfín F, Cárdenas-Tirado H, Montero-González P, Bravo-Ríos LE, Gutiérrez-Ávila C, Torres TM, Pérez-Olea MV
Desmopressin tablets in treatment of patients with central diabetes insipidus
Cir Cir 2002; 70 (2)

Language: Español
References: 22
Page: 93-97
PDF: 85.03 Kb.

Full text


Objective: To assess desmopressin tablet efficiency and safety related to treatment of central diabetes insipidus patients compared with intranasal administration. Matherial and methods: Twenty five central diabetes insipidus patients were included, 20 men and five women, with age mean of 12.7 ± 3.8 years standard deviation (SD) and 9.6 ± 3.6 years, respectively. All were treated with intranasal desmopressin. After 24 h of desensitization, desmopressin tablets at a proportion of 1:20 with respect to intranasal presentation was begun every 8 or 12h depending on urinary volumes. This phase was continued during 6 months. Twenty one patients proceeded into a second phase of tablet treatment after intranasal desmopressin reinstallation. This time, tablet do ses were adjusted after 72 h of knowing urinary volume and osmolarity, with follow-up at 2, 4, 6, and 8 weeks of treatment. Results: On comparing urinary volumes of oral against intranasal doses an increase was observed (927.7 ± 267.3 vs 1,085.4 ± 450.2 ml/m2 BS, p = Ns), with urinary osmolarity showing a slight decrease (508.3 ± 263.6 vs 333.3 ± 162.2 mOsm/kg, p = Ns). However, neither difference was statistically significant. In the second phase, mean desmopressin tablet doses were 530.9 ± 212.4 µg/day. Urinary volumes had aslight increase (1,012.7 ± 461.4 vs 1,254.7 ± 732.7 ml/m2 BS, p = Ns), with urinary osmolarity increasing to 340.7 ± 161.6 vs 365.3 ± 194.5 ml/m2 Bs, p = Ns). As before, neither difference was statistically significant. The desmopressin tablet preparation showed to be effective and safe. This is a good alternative to treat central diabetes insipidus in patients when specifically compared to intranasal solution in patients with acute or chronic nasal mucous inflammation.

Key words: , Central diabetes insipidus, Desmopressin tablets.


  1. Zaoral M, Kolc J, Sorm S. Aminoacids and peptides LXXI. Synthesis of 1-desamino-8-D-y-amino-uterine vasopressin, 1-deamino-8-D-lysine-vasopressin and 1-deamino-8-D-arginine vasopressin. Collect Czech Chem Commun 1967;32:1250-7.

  2. Seif SM, Zenser TV, Ciarochi FF, Davis BB, Robinson AG. DDA VP (1-desamino-8-D-arginine-vasopressin) treatment of central diabetes insipidus-mechanism of prolonged antidiuresis. J Clin Endocrinol Metab 1978;46:381-8.

  3. Schlondorff D, Franki N. Effect of vasopressin on cyclic AMP-dependent protein kinase in toad urinary bladder. Biochem Biophys Acta 1980;628:1-12.

  4. Fjellestad-Paulsen A, Tubiana-Rufi N, Harris A, Czernichow P. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin. Acta Endocrinol (Copenh) 1987;115:307-12.

  5. Lethagen S, Harris AS, Sjörin E, Nilsson IM. Intranasal and intravenous administration of desmopressin: effect of F VIII/v WF, pharmacokinetics and reproducibility. Thrombo Haemost 1987;58:1033-6.

  6. Harris AS, Hedner P, Vilhardt H. Nasal administration by spray and drops. J Pharm Pharmacol 1987;39:932-4.

  7. Williams TDM, Lightman SL, Leadbeater MJ. Hormonal and cardiovascular responses to DDAVP in man. Clin Endocrinol 1986;24:89-96.

  8. Hammer M, Vilhardt H. Peroral treatment of diabetes insipidus with a polypeptide hormone analogue, desmopressin. J Pharmacol Exp Ther 1985;234:754-60.

  9. Cunnah D, Ross G, Besser GM. Management of cranial diabetes insipidus with oral desmopressin (DDAVP). Clin Endocrinol 1986;24:253-7.

  10. Fjellestad A, Czernichow P. Central diabetes insipidus in children. V. Oral treatment with a vasopressin hormone analogue (DDAVP). Acta Paediatr Scand 1986;75:605-10.

  11. Williams TDM, Dunger DB, Lyon CC, Lewis RJ, Taylor F, Lightman SL. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children. J Clin Endocrinol Metab 1986;63:129-32.

  12. Westgren U, Wittstrom C, Harris AS. Oral desmopressin in central diabetes insipidus. Arch Dis Child 1986;61:247-50.

  13. Vilhardt H, Bie P. Antidiuretic effect of perorally administered DDAVP in hydrated humans. Acta Endocrinol (Copenh) 1984;105:474-6.

  14. Carraro A, Fano M, Porcella E, Bernareggi J, Giusti M. Trattamento del diabete insipido centrale con DDAVP per via orale. Confronto con il trattamento per via endonasale. Minerva Endocrinol 1991;16:141-5.

  15. Rampazzo AL, Boscaro M, Mantero F, Piccito R. Valutazione clinica della desmopressina (DDAVP) nel diabete insipido: soluzione vs compresse. Minerva Endocrinol 1992;17:37-41.

  16. Carrero A, Fano M, Cuttica M, Bernareggi V, Giusti M, Giordano G. Trattamento a lungo termine del diabete insipido centrale con DDAVP per via orale. Minerva Endocrinol 1992;17:189-93.

  17. Merola B, Caruso E, Chiara G, et al. Efficacia e tollerabilita della desmopressina in formulazione orale nel trattamento del diabete insipido centrale. Minerva Med 1992;83:805-13.

  18. Carrero A, Giusti M. Desmopressina orale nel trattamento del diabete insipido centrale. Minerva Med 1993;84:563.

  19. Fjellestad PA, Paulsen O, Abensour d’Agay L, Lundin S, Czernichow P. Central diabetes insipidus oral treatment with DDAVP. Regulatory Peptides 1993;45:303-7.

  20. Lam KS, Wat MS, Cho KL, Ip TP, Pang RW, Kumana CR. Pharmacokinetics, pharmacodynamics, long term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus. Br J Clin Pharmacol 1996;42:379-85.

  21. Boulgourdjian EM, Martínez AS, Ropelato MG, Heinrich JJ, Bergadá C. Oral desmopressin treatment of central diabetes insipidus in children. Acta Paediatr 1997;86:1261-2.

  22. Fjellestad-Paulsen A, Laborde K, Kindermans C, Czernichow P. Water-balance hormones during long-term follow-up or oral DDAVP treatment in diabetes insipidus. Acta Paediatr 1993;82:752-7.

>Journals >Cirugía y Cirujanos >Year 2002, Issue 2

· Journal Index 
· Links 

Copyright 2019